Curia is a global CDMO with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing. We offer services across Small Molecules, Generic APIs, and Biologics backed by deep scientific expertise and a robust global network of resources and capabilities.

Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact.

Steve Lavezoli is Curia’s Vice President of Biologics overseeing its discovery, development and manufacturing services. With a remarkable breadth of…

Curia’s Infection Kinetics Monitoring (IKM) technology was developed by our team of scientists to deliver unmatched reproducibility and scalability for baculovirus mediated expressions and this system is compatible with all popular kit systems that exist in the protein expression marketplace.

With the addition of LakePharma, Curia offers deep expertise in both large and small molecules from drug discovery through drug substance manufacturing, sterile injectable formulation and fill-finish production.

Our team is always exploring new frontiers in science and its impact on patient treatments. Learn more about the questions we’re asking—and the answers we’ve uncovered so far.

Curia provides scientific expertise and state-of-the-art technologies to support the chemical development and cGMP manufacture of complex APIs, including its RSMs and intermediates, generics, potent and cytotoxic compounds, sterile APIs, steroids and controlled substances.

305 Church at North Hills Street 12th Floor Raleigh, NC 27609 USA

The power of a partnership with Curia. Extensive catalog. Access to a robust portfolio of more than 240 generic and commercial APIs. Global network. 12+ GMP facilities in the US, France, Italy, Spain, UK and India. Regulator inspected. Facilities successfully inspected by the FDA, PMDA, KFDA, ANVISA, MHRA and AIFA.

Curia offers end-to-end services for antibodies, proteins, enzymes, and mRNA vaccines and therapeutics.